Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
1. Introduction Glioblastoma (GBM) is the most common primary malignant brain tumour in adults. Median survival for unselected populations ranges between 9 and 11 months, and very few patients survive for 5 years [1–3]. For patients with favourable prognostic factors, allowing for extensive, multimodal treatment with surgery, radiation (RT), chemotherapy (CT) and tumour treating fields (TTF), median survival can be prolonged to nearly 21 months [4, 5].
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
